On January 13, 2018, Deputy Dean Xv Xuehu and Director Sheng Xiujie of the Third Affiliated Hospital of Guangzhou Medical University came to our company for academic exchanges. The two parties had in-depth discussions on oncolytic virus and cell therapy and others tumor immunotherapy. Our company is about to carry out clinical research on oncolytic virus combined cell therapy in the Third Affiliated Hospital of Guangzhou Medical University.